HomeInsightsStock Comparison

Fortis Healthcare Ltd vs Nephro Care India Ltd Stock Comparison

Fortis Healthcare Ltd vs Nephro Care India Ltd Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

  • The Latest Trading Price of Fortis Healthcare Ltd is ₹ 720 as of 23 Oct 15:30 . The P/E Ratio of Fortis Healthcare Ltd changed from 39.5 on March 2022 to 57.6 on March 2026 . This represents a CAGR of 7.84% over 5 yearsThe P/E Ratio of Nephro Care India Ltd changed from 25.4 on March 2026 to 25.4 on March 2026 . This represents a CAGR of 0.00% over 1 years The Market Cap of Fortis Healthcare Ltd changed from ₹ 15023 crore on March 2021 to ₹ 59988 crore on March 2026 . This represents a CAGR of 25.96% over 6 yearsThe Market Cap of Nephro Care India Ltd changed from ₹ 85.32 crore on March 2026 to ₹ 85.32 crore on March 2026 . This represents a CAGR of 0.00% over 1 years The revenue of Fortis Healthcare Ltd for the Jun '26 is ₹ 2573 crore as compare to the Mar '26 revenue of ₹ 2375 crore. This represent the growth of 8.34% The revenue of Nephro Care India Ltd for the Jun '26 is ₹ 29.41 crore as compare to the Mar '26 revenue of ₹ 27.58 crore. This represent the growth of 6.64% The ebitda of Fortis Healthcare Ltd for the Jun '26 is ₹ 565.5 crore as compare to the Mar '26 ebitda of ₹ 530.45 crore. This represent the growth of 6.61% The ebitda of Nephro Care India Ltd for the Jun '26 is ₹ 3.84 crore as compare to the Mar '26 ebitda of ₹ 2.85 crore. This represent the growth of 34.74% The net profit of Fortis Healthcare Ltd changed from ₹ 173.98 crore to ₹ 272.8 crore over 9 quarters. This represents a CAGR of 22.13% The net profit of Nephro Care India Ltd changed from ₹ -0.65 crore to ₹ 1.61 crore over 5 quarters. This represents a CAGR of NaN% The Dividend Payout of Fortis Healthcare Ltd changed from 78.45 % on March 2023 to 32.78 % on March 2026 . This represents a CAGR of -19.60% over 4 yearsThe Dividend Payout of Nephro Care India Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Fortis Healthcare Ltd

  • Fortis Healthcare Limited (FHL) is one of the largest healthcare services providers in India with 27 hospitals, ~4,750+ operational beds and 400+ diagnostics centres as of 31 March, 2025.
  • The Company offers a full spectrum of integrated healthcare services ranging from clinics to quaternary care facilities and a wide range of ancillary services to patients in areas such as Cardiac Care, Orthopedics, Neurosciences, Oncology, renal care, Gastroenterology and Mother and Child care..
  • They are delivering quality healthcare services to patients in modern facilities using advanced technology. SRL Limited, a subsidiary of FHL is primarily involved in providing diagnostics services and is amongst the leading diagnostics chains in India with a significant market share in the organized diagnostics segment.

About Nephro Care India Ltd

  • Nephro Care India Limited was originally incorporated on July 08, 2014 as a Private Limited Company as 'Nephro Care India Private Limited' with the Registrar of Companies, West Bengal.
  • Subsequently, Company converted into a Public Limited Company and the name of Company was changed to Nephro Care India Limited' and a fresh Certificate of Incorporation dated March 5, 2024, was issued by the Registrar of Companies, Central Processing Centre. Nephro Care was founded in the year 2014 by Dr. Pratim Sengupta in Kolkata with an object of providing comprehensive medical services for renal patients.
  • The Company is a one stop treatment centre based in Kolkata that offer clinical and lifestyle solutions and services and renal insufficiency treatment to patients.
  • The treatment framework covers the entire range of lifestyle, physiological and spiritual aspects of wellness.

FAQs for the comparison of Fortis Healthcare Ltd and Nephro Care India Ltd

Which company has a larger market capitalization, Fortis Healthcare Ltd or Nephro Care India Ltd?

Market cap of Fortis Healthcare Ltd is 54,356 Cr while Market cap of Nephro Care India Ltd is 136 Cr

What are the key factors driving the stock performance of Fortis Healthcare Ltd and Nephro Care India Ltd?

The stock performance of Fortis Healthcare Ltd and Nephro Care India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Fortis Healthcare Ltd and Nephro Care India Ltd?

As of October 25, 2026, the Fortis Healthcare Ltd stock price is INR ₹720.0. On the other hand, Nephro Care India Ltd stock price is INR ₹83.0.

How do dividend payouts of Fortis Healthcare Ltd and Nephro Care India Ltd compare?

To compare the dividend payouts of Fortis Healthcare Ltd and Nephro Care India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions